Format

Send to

Choose Destination
See comment in PubMed Commons below
Front Immunol. 2012 Feb 7;3:13. doi: 10.3389/fimmu.2012.00013. eCollection 2012.

Targeting Dendritic Cells in vivo for Cancer Therapy.

Author information

  • 1Immunology Division, The Walter and Eliza Hall Institute of Medical Research Melbourne, VIC, Australia.

Abstract

Monoclonal antibodies that recognize cell surface molecules have been used deliver antigenic cargo to dendritic cells (DC) for induction of immune responses. The encouraging anti-tumor immunity elicited using this immunization strategy suggests its suitability for clinical trials. This review discusses the complex network of DC, the functional specialization of DC subsets, the immunological outcomes of targeting different DC subsets and their cell surface receptors, and the requirements for the induction of effective anti-tumor CD4 and CD8 T cell responses that can recognize tumor-specific antigens. Finally, we review preclinical experiments and the progress toward targeting human DC in vivo.

KEYWORDS:

antigen delivery; dendritic cell subsets; dendritic cells; targeting; vaccine

PMID:
22566899
PMCID:
PMC3342351
DOI:
10.3389/fimmu.2012.00013
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontiers Media SA Icon for PubMed Central
    Loading ...
    Support Center